Top Tech Companies (764)
Don't see your company?
Create a company profile
PRECISIONscientia, formerly ETHOS Health Communications, was founded in 2002 with the vision of translating the science of medicine into clinical benefit. Today, we continue to live and work by the same guiding principles that established our beliefs, shaped our culture, and influenced who we hire, and remind us of our commitment. Over the years, the mediums and channels have evolved, but our belief in the power of medicine and devotion to the highest level of accuracy and integrity remain unchanged. In 2018, PRECISIONscientia joined the Precision Value & Health network of Precision Medicine Group. All that precision comes together to offer expertise and guidance throughout the entire commercial lifecycle of a medical innovation.
Claritas Rx is a digital health venture that brings clarity to the challenges of specialty biopharmaceutical products in the marketplace. In today’s highly complex specialty networks, our mission is to illuminate the patient experience beyond the clinical trial. Claritas Rx leverages a proprietary technology platform and deep manufacturer expertise to automate and integrate channel, commercial, and clinical data and help biopharmaceutical companies generate actionable business insights. Our work uncovers the real-world variables impacting patient access, duration of therapy, and other metrics key to commercial success, making a real impact on patient healthcare.
Incisive Surgical, Inc. is a privately-held medical device company established to develop proprietary mechanical surgical solutions for
Waltz Health is a Chicago-based technology startup that is leading a new way forward for prescription care. We're rethinking the pharmaceutical supply chain, introducing AI-driven marketplaces that drive down costs, and new consumer tools that guide decisions on care. Led by a team of industry experts, Waltz is fixing the high costs and broken experiences that define our pharmaceutical supply chain. We believe that better pricing, more information and smarter tools can lower costs, empower consumers and help payers take control of their pharmacy benefits. The technology we are building is the start of a new way of working together - making better outcomes possible for all.
ReCode Therapeutics is a biopharmaceutical company developing precision medicines for pulmonary diseases.
Escient Pharmaceuticals is a privately held biotechnology company.
NextSource Biotechnology is a biotechnology and pharmaceutical company located in Miami.
Delivering through technology
RayzeBio is focused on improving outcomes for people with cancer by harnessing the power of targeted radioisotopes.
Lumena Pharmaceuticals develops oral therapeutics for rare liver diseases to improve liver function and relieve disease symptoms.
Optimizing Health by Advancing the Quality of Medication Use.
We are a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined diseases in areas of high unmet medical need, with an initial focus on rare diseases. Community Guidelines: https://bit.ly/3t2xeR9
Vivione is a TSX Venture Exchange listed biosciences company focused on the commercialization of its proprietary RAPID-B system.
We are Körber – an international technology group with about 10,000 employees, more than 100 locations worldwide and a common goal: We turn entrepreneurial thinking into customer success and shape technological change. In the Business Area Pharma we deliver the difference along the entire pharmaceutical value chain by offering a unique portfolio of integrated solutions. Based on in-depth experience, we understand the challenges in pharmaceutical processes and regulation that our customers face day to day, from the beginning to the end of their production. • Consulting As the personal partner and pharma technology expert, Körber delivers industry leading consultancy supporting you from requirement analysis to project implementation. • Inspection With world leading high-performance inspection machines, semi-automatic and laboratory equipment and inspection applications, Körber offers an unrivaled level of quality for customized inspection solutions. • Handling With complete handling systems for pharmaceutical and medical products, Körber delivers automated, flexible and secure product transport and tray systems. • Track & Trace As the partner for integrated Track & Trace solutions from level 1 to level 5, Körber delivers the difference through coding, serialization and aggregation to data management all from one source. • Packaging machines As a leading supplier of primary and secondary pharmaceutical packaging machines, Körber delivers the difference by maximizing the OEE of your lines and providing flexibility to address future market requirements. • Software With our world leading PAS-X Manufacturing Execution System (MES) and software solutions, Körber delivers the difference by unlocking the potential of pharmaceutical and biotech value chains. • Packaging materials As the specialist in pharmaceutical cardboard packaging, Körber delivers innovative and high-quality packaging solutions that make the difference.
Established in 2005, Bioscript Group is formed from multiple, specialist businesses to support our global pharmaceutical clients; we draw on their multidisciplinary expertise to help navigate critical decisions at key points in the product lifecycle. Our scientific and strategic expertise help our clients make better decisions. We provide medical communication services, market access consulting and regulatory writing support with deep domain expertise to effectively navigate complex disease areas.
Through advancing research, observing natural behavior, and listening to our customers, Medela turns science into care while nurturing health for generations. Medela supports millions of moms, babies, patients, and healthcare professionals in more than 100 countries all over the world. As the healthcare choice for more than 6 million hospitals and homes across the globe, Medela provides the leading research-based breast milk feeding and baby products, healthcare solutions for hospitals, and clinical education. A family-owned company, Medela has 20 subsidiaries in Europe, the Americas, Asia and Australia, three production and warehouse facilities in Switzerland, the U.S and China and a worldwide distribution network in over 100 countries. With more than 1,500 employees, Medela is dedicated to developing breakthrough innovations that build better health outcomes and improve the lives of moms, babies and patients. Founded in 1961 by Olle Larsson, his son Michael Larsson serves as Chairman of the Board of Directors since 2001. Annette Brüls is the CEO of the company since 2018. Medela is committed to providing equal employment opportunity (EEO) to all persons regardless of race, religion, color, national origin, ancestry, citizenship, sex, protected veteran status, age, physical or mental disability, medical condition, HIV/AIDS status, marital or domestic partner status, sexual orientation, gender identity, or any other characteristic protected by federal, state, or local law or ordinance
Athenex is a global specialty oncology pharmaceutical company focused on the development and commercialization of next generation therapies for cancer diseases and supportive therapies. The company is dedicated to delivering innovative drugs that can have a life-changing impact on cancer patients. Our business includes medical technology innovation centers and a unique manufacturing supply chain across both China and North America. Through the connected innovation and manufacturing supply chain presence, we can identify, develop and deliver proprietary medical technology across continents and multiple regulatory environments.
US WorldMeds is a closely-held, Kentucky-based specialty pharmaceutical company. Our mission is to develop, license and commercialize
Transforming Healthcare with Innovation Multiplier AI is a leading force in the Healthcare industry, providing cutting-edge solutions to global brands like Galderma, Abbott, Merck, Cipla, Mankind, and more. With a team of 70+ dedicated professionals, we specialize in Generative AI, data insights, and physician influencer marketing, driving growth and transformation in the Healthcare landscape. Our Expertise: Generative AI and Personalized Marketing Our expertise lies in harnessing the power of Generative AI to create personalized, impactful marketing campaigns. Through advanced algorithms, we generate compelling content, captivating visuals, and optimized messaging that resonate with target audiences, maximizing engagement and impact. Data Insights: Uncovering Opportunities for Growth By extracting valuable insights from complex datasets, we enable our clients to make informed decisions and drive business growth. Our data-driven approach uncovers hidden patterns, identifies market trends, and keeps our clients ahead of the competition. Physician Influencer Marketing: Building Credibility and Thought Leadership We understand the influential role of physicians in the Healthcare industry. With our specialized physician influencer marketing services, we connect Pharma companies with influential doctors who shape opinions and drive brand awareness. Through strategic partnerships with key opinion leaders (KOLs), we help clients build credibility, establish thought leadership, and enhance brand reputation. Join us in Transforming Pharma & Healthcare To know more contact : US: 1-925-217-7578 India: (+91)- 9100379991 Email: [email protected] Website: https://multipliersolutions.com/
CONTINUUS’ mission is to produce high-quality drugs that can be delivered to patients more effectively and at a lower cost. In achieving this goal, we look to radically transform the pharmaceutical manufacturing industry, steering it away from outdated batch systems to state-of-the-art continuous processes. CONTINUUS is leveraging a novel continuous manufacturing platform called Integrated Continuous Manufacturing (ICM), initially developed through an $85 M joint research project between Novartis and MIT. With ICM, we will improve affordability and accessibility of pharmaceuticals on a global scale. Our work is critical because the current manufacturing systems are time- and cost-inefficient, and are beset with quality problems. It is not unusual for manufacturing lead times, from start to finish, to be over one year, and studies have shown that the industry loses over $50 B annually due to wasteful processes. More importantly, these problems impact patient care. Hundreds of drugs are placed on the US FDA drug shortage website, many of which are life-saving (e.g., oncology drugs). To solve these problems, we offer a number of solutions: In addition, CONTINUUS is currently collaborating with hospital systems and pharmacy chains to establish its own generic business, where high-quality, low-cost drugs will be manufactured in the United States. To achieve our goals, CONTINUUS has assembled a team of talented engineers and scientists, with skills ranging from analytical chemistry to drug formulation. Rather than producing medicines through batch-wise, step-by-step processes, ICM allows for fully continuous and automated operations, where the synthesis of the active ingredient and the final dosage form are integrated into a seamless process. This novel method will allow “on-demand” manufacturing of pharmaceuticals, improving affordability and accessibility of pharmaceuticals on a global scale.
